CTA
PBH icon

Carillon Tower Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Carillon Tower Advisers’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-294,541
Closed -$404K – 472
2017
Q4 		$404K Buy
+294,541
New +$13.4M 4.3% 1

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Carillon Tower Advisers's PBH Position: Q1 2018 in Review

Carillon Tower Advisers sold out of Prestige Consumer Healthcare (PBH) in Q1 2018, closing a stake of 294,541 shares — an estimated $404K sold.

Carillon Tower Advisers first reported a position in PBH in Q4 2017 and held it in 1 quarter. The position peaked at $404K in Q4 2017. 239 funds tracked by Wall St. Rank hold PBH as of Q1 2018.

  • Carillon Tower Advisers reported no remaining Prestige Consumer Healthcare position as of Q1 2018 after selling out during the quarter.
  • Carillon Tower Advisers sold 294,541 Prestige Consumer Healthcare shares in Q1 2018, an estimated $404K.
  • Carillon Tower Advisers first reported a position in Prestige Consumer Healthcare in Q4 2017 and held it in 1 quarter.
  • Carillon Tower Advisers's Prestige Consumer Healthcare position peaked at $404K in Q4 2017.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2018.

Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.